Exondys 51’s Development: Was Placebo-Controlled Trial Possible?
Sarepta says US FDA said ‘no,’ but agency repeatedly urged the company to pursue the approach.
Sarepta says US FDA said ‘no,’ but agency repeatedly urged the company to pursue the approach.